RT Journal Article
SR Electronic
T1 Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.13.24310236
DO 10.1101/2024.07.13.24310236
A1 Chopra, Shruti
A1 Roesner, Lennart M.
A1 Döhner, Katinka
A1 Zeitvogel, Jana
A1 Traidl, Stephan
A1 Rodriguez, Elke
A1 Harder, Inken
A1 Lieb, Wolfgang
A1 Weidinger, Stephan
A1 Schulz, Thomas F.
A1 Sodeik, Beate
A1 Werfel, Thomas
YR 2024
UL http://medrxiv.org/content/early/2024/07/19/2024.07.13.24310236.abstract
AB Eczema herpeticum (EH) is a potentially life-threatening disseminated skin infection caused by herpes simplex virus (HSV) in a subset of patients with atopic dermatitis (AD). Genetic factors play a pivotal role in EH development. Herein, we identify a single nucleotide polymorphism (SNP) rs2973744 in the gene encoding collagen XXIII alpha 1 chain (Col23a1) as a novel genetic risk factor for EH using whole exome sequencing. EH-patient-derived primary keratinocytes carrying the SNP rs2973744 show elevated COL23A1 mRNA and total protein levels as well as increased susceptibility to HSV-1. We discover that increasing Col23a1 levels enhances HSV-1 infection in human keratinocytes. The transcriptomic analysis unveils that COL23A1 overexpression dampens keratinocyte immune responses, thereby elucidating the molecular mechanism underlying exacerbated HSV-1 susceptibility. Our findings report a novel potential screening marker and therapeutic target for EH and reveal Col23a1’s unexplored role in HSV-1 pathogenesis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by EXNet-0030-Phase2-3 Communities allied in infection (COALITION) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germanys Excellence Strategy-EXC 2155 RESIST- project ID 39087428.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Hannover Medical School (No. 8733_BO_S_2019) approved this study and all study participants provided written informed consent. DNA samples from AD patients with and without a history of EH were derived from the GENEVA cohort, Biobank of the University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.ADatopic dermatitisADEH+AD patients with a history of eczema herpeticumADEH-AD patients without a history of eczema herpeticumChemCherryCol23a1collagen type XXIII alpha 1 chainEearly HSV-1 geneEHeczema herpeticumFIfurin inhibitor IGFPgreen fluorescent proteinGOGene OntologyHpihours post-infectionHSV-1herpes simplex virus type 1IEimmediate-early HSV-1 geneLlate HSV-1 geneMARCOmacrophage receptor with collagenous structureMOImultiplicity of infectionmRNAmessenger RNAPCRpolymerase chain reactionPfuplaque-forming unitqPCRquantitative PCRRNA-seqRNA sequencingRT-PCRreverse transcription PCRRT-qPCRquantitative RT-PCRSDstandard deviationSNPsingle nucleotide polymorphismWTwild type.